SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193805-23-000637
Filing Date
2023-05-01
Accepted
2023-05-01 17:00:13
Documents
8
Period of Report
2023-06-28

Document Format Files

Seq Description Document Type Size
1 e618561_def14a-immunic.htm DEF 14A 702048
2 GRAPHIC image_001.jpg GRAPHIC 6573
3 GRAPHIC image_001.gif GRAPHIC 13281
4 GRAPHIC image_002.gif GRAPHIC 13808
5 GRAPHIC image_002.jpg GRAPHIC 1758
6 GRAPHIC image_006.jpg GRAPHIC 631
7 GRAPHIC image_003.jpg GRAPHIC 788
8 GRAPHIC image_005.jpg GRAPHIC 746
  Complete submission text file 0001193805-23-000637.txt   755918
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36201 | Film No.: 23874753
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences